🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Efficacy and Safety

Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC) NCT07627347NA1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: anlotinib+bevacizumab AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea NCT07571109Phase 392 sites📍 Gilbert📍 Bradenton📍 Naples Novo Nordisk A/S · Tests: NNC0487-0111, Placebo (matched to NNC0487-0111) Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device NCT07531199NA1 site📍 Avranches Hôpital Privé de la Baie · Tests: Classical surgery, Intraluminal suture Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities NCT06760221NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: stereotactic body raiotherapy Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors NCT07408258Phase 13 sites📍 New York📍 Philadelphia📍 Houston OncoC4, Inc. · Tests: ONC-783 A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation NCT06908434Phase 11 site📍 Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenSci128 tablets Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease NCT06388863NA1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Healthy donor-derived FMT capsule, Placebo capsule Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder NCT07420816Phase 21 site📍 Bragança Paulista Apsen Farmaceutica S.A. · Tests: APSTZD 1, APSTZD 2, APSTZD 3, APSTZD 4, Stilnox CR® A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site📍 London Hemab ApS · Tests: Sutacimig, Sutacimig Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-1801 CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry NCT06238765n/a1 site📍 Waltham CorEvitas Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites📍 Aalborg📍 Vejle CSL Behring · Tests: CE1226 Phase III Study of OT202 in Treating Moderate to Severe Dry Eye NCT07740564Phase 349 sites📍 Bengbu📍 Hefei📍 Beijing Ocumension Therapeutics (Suzhou) Co., Ltd · Tests: OT202 conc 1%, Placebo Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL NCT07244406Phase 21 site📍 Beijing Hebei Senlang Biotechnology Inc., Ltd. · Tests: S1904 CD19 CAR-T Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms NCT06613438NA5 sites📍 Chicago📍 Afula📍 Haifa Gerd Care Medical Ltd · Tests: eGERD device, eGERD_Sham The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease NCT06608355Phase 11 site📍 Wuhan iRegene Therapeutics Co., Ltd. · Tests: Human Dopaminergic Progenitor Cells A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis NCT07499700Phase 2, Phase 31 site📍 Beijing Bio-Thera Solutions · Tests: BAT4406F, Placebos Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST) NCT07094711Phase 21 site📍 Charlottesville University of Virginia · Tests: Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine, preservative-free saline Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers NCT07158658NA2 sites📍 Bossier City📍 Rayville NuScience Medical Biologics, LLC · Tests: NeoThelium FT (HCT/P 361) Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer NCT07367516Phase 1, Phase 230 sites📍 Hefei📍 Beijing📍 Fuzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQB6411 Injection Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer NCT06008119Phase 31 site📍 Beijing Shanghai Kechow Pharma, Inc. · Tests: Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma NCT07599371Phase 1, Phase 21 site📍 Zhengzhou The First Affiliated Hospital of Zhengzhou University · Tests: Ivoximab 20 mg/kg, ivgtt, Q4W, Temozolomide (TMZ) Safety and Efficacy of Pucotenlimab in pLECC NCT06969534Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Pucotenlimab combined with GP regimen Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) NCT05686434Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Osimertinib A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT07230730Phase 31 site📍 Hangzhou Beijing Suncadia Pharmaceuticals Co., Ltd · Tests: SHR-1918, SHR-1918 placebo A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma NCT06767800Phase 239 sites📍 Fuyang📍 Lu'an📍 Maanshan Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQB2102 for injection (7.5 mg) +Benmelstobart+Chemotherapy, TQB2102 for injection (6 mg/7.5 mg) +Benmelstobart+Chemothe… TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site📍 Hangzhou Shenzhen TargetRx Co., Ltd. · Tests: TGRX-1942
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy